Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Aripiprazole — Abilify®

Brand: Abilify®
NICE TA: 292
Indication: Bipolar disorder in Adolescents (NICE TA292)
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

Aripiprazole is recommended as an option for treating moderate to severe manic episodes in adolescents with bipolar I disorder, within its marketing authorisation (that is, up to 12 weeks of treatment for moderate to severe manic episodes in bipolar I disorder in adolescents aged 13 and older)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Amber1

Red